Literature DB >> 31040177

The quantitative relationship between isotopic and net contributions of lactate and glucose to the tricarboxylic acid (TCA) cycle.

Minfeng Ying1, Cheng Guo1, Xun Hu2.   

Abstract

Whether growing cancer cells prefer lactate as a fuel over glucose or vice versa is an important but controversial issue. Labeling of tricarboxylic acid (TCA) cycle intermediates with glucose or lactate isotope tracers is often used to report the relative contributions of these two metabolites to the TCA cycle. However, this approach may not yield accurate results, as isotopic labeling may not accurately reflect net contributions of each metabolite. This may be due to isotopic exchange occurring during the conversion between pyruvate and lactate. To evaluate this quantitatively, we used an equation (C G - C G' = C L' - C L) assessing the relationship between isotopic labeling and net consumption measurements in vitro. C G and C L refer to the contributions of glucose and lactate to the TCA cycle as measured by their net consumption, whereas C G' and C L' refer to glucose's and lactate's contributions determined with isotopic labeling. We found that the isotopic labeling data overestimate the net contribution of lactate to the TCA cycle and underestimate that of glucose. The overestimated amount is equal to the isotopic exchange amount between pyruvate and lactate. After excluding the interference of isotopic exchange, the major carbon contribution (i.e. acetyl-CoA) to the TCA cycle comes from glucose rather than lactate in vitro We propose that these relative contributions of glucose and lactate may also be present in cancer cells in vivo.
© 2019 Ying et al.

Entities:  

Keywords:  13C labeling; glucose; isotope exchange; isotopic tracer; lactic acid; metabolic flux; net contribution; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); tumor metabolism

Mesh:

Substances:

Year:  2019        PMID: 31040177      PMCID: PMC6579476          DOI: 10.1074/jbc.RA119.007841

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Stable isotope tracer analysis by GC-MS, including quantification of isotopomer effects.

Authors:  J Rosenblatt; D Chinkes; M Wolfe; R R Wolfe
Journal:  Am J Physiol       Date:  1992-09

2.  THE METABOLISM OF GLUTAMATE IN HOMOGENATES AND SLICES OF BRAIN CORTEX.

Authors:  R J HASLAM; H A KREBS
Journal:  Biochem J       Date:  1963-09       Impact factor: 3.857

3.  Microvascular architecture of experimental colon tumors in the rat.

Authors:  S A Skinner; P J Tutton; P E O'Brien
Journal:  Cancer Res       Date:  1990-04-15       Impact factor: 12.701

4.  A potential pitfall in the use of isotopes to measure ketone body production.

Authors:  B R Landau
Journal:  Metabolism       Date:  1986-01       Impact factor: 8.694

5.  Lactate production cannot be measured with tracer techniques.

Authors:  K Sahlin
Journal:  Am J Physiol       Date:  1987-03

Review 6.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

7.  Tumor metabolism: cancer cells give and take lactate.

Authors:  Gregg L Semenza
Journal:  J Clin Invest       Date:  2008-11-20       Impact factor: 14.808

8.  THE METABOLISM OF TUMORS IN THE BODY.

Authors:  O Warburg; F Wind; E Negelein
Journal:  J Gen Physiol       Date:  1927-03-07       Impact factor: 4.086

9.  PDK1 inhibition is a novel therapeutic target in multiple myeloma.

Authors:  S Fujiwara; Y Kawano; H Yuki; Y Okuno; K Nosaka; H Mitsuya; H Hata
Journal:  Br J Cancer       Date:  2012-11-29       Impact factor: 7.640

10.  PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer.

Authors:  S M Wigfield; S C Winter; A Giatromanolaki; J Taylor; M L Koukourakis; A L Harris
Journal:  Br J Cancer       Date:  2008-06-10       Impact factor: 7.640

View more
  10 in total

1.  Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer.

Authors:  Kasey R Cargill; C Allison Stewart; Elizabeth M Park; Kavya Ramkumar; Carl M Gay; Robert J Cardnell; Qi Wang; Lixia Diao; Li Shen; You-Hong Fan; Wai Kin Chan; Philip L Lorenzi; Trudy G Oliver; Jing Wang; Lauren A Byers
Journal:  Cancer Metab       Date:  2021-09-23

2.  Perturbation of phosphoglycerate kinase 1 (PGK1) only marginally affects glycolysis in cancer cells.

Authors:  Chengmeng Jin; Xiaobing Zhu; Hao Wu; Yuqi Wang; Xun Hu
Journal:  J Biol Chem       Date:  2020-03-26       Impact factor: 5.157

Review 3.  A framework for examining how diet impacts tumour metabolism.

Authors:  Evan C Lien; Matthew G Vander Heiden
Journal:  Nat Rev Cancer       Date:  2019-09-17       Impact factor: 60.716

4.  Lactate oxidative phosphorylation by annulus fibrosus cells: evidence for lactate-dependent metabolic symbiosis in intervertebral discs.

Authors:  Dong Wang; Robert Hartman; Chao Han; Chao-Ming Zhou; Brandon Couch; Matias Malkamaki; Vera Roginskaya; Bennett Van Houten; Steven J Mullett; Stacy G Wendell; Michael J Jurczak; James Kang; Joon Lee; Gwendolyn Sowa; Nam Vo
Journal:  Arthritis Res Ther       Date:  2021-05-21       Impact factor: 5.156

Review 5.  In vivo2H/13C flux analysis in metabolism research.

Authors:  Tomasz K Bednarski; Mohsin Rahim; Jamey D Young
Journal:  Curr Opin Biotechnol       Date:  2021-05-25       Impact factor: 10.279

6.  Impaired anaplerosis is a major contributor to glycolysis inhibitor toxicity in glioma.

Authors:  Sunada Khadka; Kenisha Arthur; Yasaman Barekatain; Eliot Behr; Mykia Washington; Jeffrey Ackroyd; Kaitlyn Crowley; Pornpa Suriyamongkol; Yu-Hsi Lin; Cong-Dat Pham; Rafal Zielinski; Marissa Trujillo; James Galligan; Dimitra K Georgiou; John Asara; Florian Muller
Journal:  Cancer Metab       Date:  2021-06-25

7.  Lactic acidosis induces resistance to the pan-Akt inhibitor uprosertib in colon cancer cells.

Authors:  Emily M E Barnes; Yitao Xu; Adrian Benito; Lili Herendi; Alexandros P Siskos; Eric O Aboagye; Anke Nijhuis; Hector C Keun
Journal:  Br J Cancer       Date:  2020-03-10       Impact factor: 7.640

Review 8.  Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion.

Authors:  Peter Kreuzaler; Yulia Panina; Joanna Segal; Mariia Yuneva
Journal:  Mol Metab       Date:  2019-10-10       Impact factor: 7.422

9.  Lactate and glutamine support NADPH generation in cancer cells under glucose deprived conditions.

Authors:  Minfeng Ying; Duo You; Xiaobing Zhu; Limeng Cai; Siying Zeng; Xun Hu
Journal:  Redox Biol       Date:  2021-07-11       Impact factor: 11.799

10.  Lactate dehydrogenases amplify reactive oxygen species in cancer cells in response to oxidative stimuli.

Authors:  Hao Wu; Yuqi Wang; Minfeng Ying; Chengmeng Jin; Jiangtao Li; Xun Hu
Journal:  Signal Transduct Target Ther       Date:  2021-06-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.